Showing results (421-430 of 431) with videos related to

Sort By:
Pageof 44
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 21, 2015
An international study to increase concordance in Ki67 scoringMei-Yin C Polley, Samuel C Y Leung, Dongxia Gao, et al.
JNCI Cancer Spectrum|April 28, 2020
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research DirectionsRyan J O Dowling, Joseph A Sparano, Pamela J Goodwin, et al.
JNCI Cancer Spectrum|April 28, 2020
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical ConsiderationsRyan J O Dowling, Kevin Kalinsky, Daniel F Hayes, et al.
The New England Journal of Medicine|December 16, 2021
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast CancerKevin Kalinsky, William E Barlow, Julie R Gralow, et al.
The New England Journal of Medicine|June 5, 2018
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
The New England Journal of Medicine|June 4, 2019
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast CancerJoseph A Sparano, Robert J Gray, Peter M Ravdin, et al.
NPJ Breast Cancer|July 20, 2017
Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaborationSamuel C Y Leung, Torsten O Nielsen, Lila Zabaglo, et al.
The New England Journal of Medicine|September 29, 2015
Prospective Validation of a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Histopathology|April 25, 2019
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaborationSamuel C Y Leung, Torsten O Nielsen, Lila A Zabaglo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled AnalysisWolfgang Janni, Thomas W P Friedl, Tracy C Yab, et al.
Pageof 44